CBD-based medical treatments for animals will need government approval before being sold in the UK, after the country’s Veterinary Medicines Directorate (VMD) decided this month that they fall under the definition of veterinary medicines.

The relevant legislation, the Veterinary Medicines Regulations (VMR) of 2013, includes in its definition “any substance or combination of substances that may be used in, or administered to, animals with a view either to restoring, correcting or modifying physiological functions by exerting a pharmacological, immunological or metabolic action, or to making a medical diagnosis”.

Veterinary products can also fall into the category by presentation, if they are “presented as having properties for treating or preventing disease in animals”.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us